Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin–angiotensin system inhibitors in type 2 diabetic patients with albuminuria

OBJECTIVE: Concomitant treatment with angiotensin-converting enzyme (ACE) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors is increasingly common. Pharmacological studies have suggested a potential adverse drug interaction between ACE inhibitors and DPP-4 inhibitors resulting in unfavorable...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Hypertens
Main Authors: Cooper, Mark E., Perkovic, Vlado, Groop, Per-Henrik, Hocher, Berthold, Hehnke, Uwe, Meinicke, Thomas, Koitka-Weber, Audrey, van der Walt, Sandra, von Eynatten, Maximilian
Formato: Artigo
Idioma:Inglês
Publicado: Lippincott Williams & Wilkins 2019
Assuntos:
ORIGINAL PAPERS: Treatment
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6513080/
https://ncbi.nlm.nih.gov/pubmed/30540657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HJH.0000000000002032
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares